Cormorant Asset Management’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $11.5M | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $1.01M | Hold |
|
|||||
|
2022
Q1 | $1.24M | Sell |
|
|||||
|
2021
Q4 | $3.48M | Sell |
|
|||||
|
2021
Q3 | $10.4M | Hold |
|
|||||
|
2021
Q2 | $9.98M | Sell |
|
|||||
|
2021
Q1 | $14M | Hold |
|
|||||
|
2020
Q4 | $14M | Hold |
|
|||||
|
2020
Q3 | $9.59M | Sell |
|
|||||
|
2020
Q2 | $19.8M | Sell |
|
|||||
|
2020
Q1 | $15.7M | Buy |
|
|||||
|
2019
Q4 | $5.93M | Sell |
|
|||||
|
2019
Q3 | $20.7M | Sell |
|
|||||
|
2019
Q2 | $39.5M | Sell |
|
|||||
|
2019
Q1 | $67.2M | Sell |
|
|||||
|
2018
Q4 | $70.5M | Sell |
|
|||||
|
2018
Q3 | $113M | Sell |
|
|||||
|
2018
Q2 | $87.6M | Buy |
|
|||||
|
2018
Q1 | $115M | Sell |
|
|||||
|
2017
Q4 | $126M | Buy |
|
|||||
|
2017
Q3 | $35M | Buy |
|
|||||
|
2017
Q2 | $19.1M | Sell |
|
|||||
|
2017
Q1 | $24.9M | Buy |
|